AC005488.1 | Uncharacterized protein | | | | | | Group enriched |
AC006014.1 | Uncharacterized protein | | | | | | Group enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
ETNPPL | Ethanolamine-phosphate phospho-lyase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GLYATL2 | Glycine-N-acyltransferase-like 2 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
KIAA1024 | KIAA1024 | Predicted membrane proteins
| | | | | Group enriched |
KLK1 | Kallikrein 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
NKAIN3 | Na+/K+ transporting ATPase interacting 3 | Predicted membrane proteins
| | | | | Group enriched |
NXPE4 | Neurexophilin and PC-esterase domain family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
PAX9 | Paired box 9 | Disease related genes Transcription factors
| | | | | Group enriched |
PITX1 | Paired-like homeodomain 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SCGB3A1 | Secretoglobin, family 3A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM213 | Transmembrane protein 213 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Transporters
| | | | | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | | | | | Group enriched |
C5orf46 | Chromosome 5 open reading frame 46 | Predicted secreted proteins
| | | | | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
DHRS2 | Dehydrogenase/reductase (SDR family) member 2 | | | | | | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
IL19 | Interleukin 19 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KRT23 | Keratin 23 (histone deacetylase inducible) | | | | | | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| | | | | Group enriched |
MIA | Melanoma inhibitory activity | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
MUC19 | Mucin 19, oligomeric | Predicted secreted proteins
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PTCH2 | Patched 2 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TFAP2B | Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |